Cover Image
市場調查報告書

EpiCast Report:麩質過敏症的流行病學預測

EpiCast Report: Celiac Disease - Epidemiology Forecast to 2023

出版商 GlobalData 商品編碼 318757
出版日期 內容資訊 英文 45 Pages
訂單完成後即時交付
價格
Back to Top
EpiCast Report:麩質過敏症的流行病學預測 EpiCast Report: Celiac Disease - Epidemiology Forecast to 2023
出版日期: 2014年11月10日 內容資訊: 英文 45 Pages
簡介

在全球主要6個國家(美國、法國、德國、義大利、西班牙、英國),麩質過敏症和確診的患者數,預計2023年到111萬人,增加4.61%。

本報告提供全球主要6個國家的麩質過敏症調查分析、疾病的背景、危險因素和共生病症、全球趨勢、流行病學預測等相關的系統性資訊。

第1章 目錄

第2章 簡介

第3章 流行病學

  • 疾病的背景
  • 危險因素和共生病症
  • 全球趨勢
    • 美國
    • EU5個國家
  • 預測手法
    • 利用之資訊來源
    • 未利用之資訊來源
    • 預測的前提條件與手法,麩質過敏症的總患者數
    • 預測的前提條件,麩質過敏症和確診的患者數
  • 麩質過敏症的流行病學預測
    • 麩質過敏症的整體患者數
    • 麩質過敏症的整體患者數(各年齡)
    • 麩質過敏症的整體患者數(性別)
    • 麩質過敏症的整體患者數(年齡標準化)
    • 麩質過敏症和確診的患者數
  • 議論
    • 流行病學預測相關考察
    • 分析的限制
    • 分析的優勢

第4章 附錄

圖表

目錄
Product Code: GDHCER083-14

Celiac disease is an autoimmune disease that occurs in individuals who consume gluten-containing foods but are intolerant to gluten, a protein found in many grains, such as wheat, rye, and barley. In celiac disease, the body's immune system attacks and destroys the villi of the small intestine and thus interferes with nutrient absorption. Celiac disease can be difficult to diagnose because the symptoms vary between individuals and are non-specific, such as abdominal bloating and pain, diarrhea, constipation, and weight loss. Short-term malicious effects of untreated celiac disease include malnutrition, vitamin and mineral deficiency, and anemia, whereas long-term effects include bone diseases, cancers, and liver diseases. Celiac disease can arise in individuals of all ages and current epidemiological studies estimate that celiac disease affects around 1% of the population in western countries, with a range of between 0.3-2.7%.

GlobalData epidemiologists forecast that the number of total prevalent cases of celiac disease in the 6MM is expected to grow to 8.08 million cases in 2023 at a rate of 3.92% per year during the forecast period. The number of diagnosed prevalent cases in the 6MM is expected to increase by 4.61% over the next decade to 1.11 million cases in 2023.

GlobalData's forecast and analysis is based on a thorough literature review and from primary research results. GlobalData epidemiologists carefully reviewed and selected secondary research studies and validated the findings with primary research. GlobalData epidemiologists maintained a consistent case-finding definition and forecasting methodology for celiac disease throughout the 6MM, thus allowing for a meaningful comparison of the total and diagnosed prevalent cases of celiac disease in these markets. The total prevalent cases of celiac disease are also segmented by sex, thus providing a detailed analysis of the patient population characteristic of celiac disease. Furthermore, GlobalData epidemiologists also provided a realistic trend forecast for the total and diagnosed prevalence of celiac disease based on insights gained through the analysis of historical data.

Scope

  • The celiac disease EpiCast Report provide an overview of the risk factors, comorbidities, and the global and historical trends for celiac disease in the six major markets (6MM) (US, France, Germany, Italy, Spain, and UK). In addition, the report also includes a 10-year epidemiological forecast for the total prevalent cases of celiac disease segmented by sex and age (0-19 years, 20-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, and =70 years), and a 10-year epidemiological forecast for the diagnosed prevalent cases of celiac disease in the 6MM.
  • The celiac disease epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
  • The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 6MM.

Reasons to buy

  • Develop business strategies by understanding the trends shaping and driving the global celiac disease market.
  • Quantify patient populations in the global celiac disease market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for celiac disease therapeutics in each of the markets covered.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports
  • 2.3. Upcoming Reports

3. Epidemiology

  • 3.1. Disease Background
  • 3.2. Risk Factors and Comorbidities
  • 3.3. Global Trends
    • 3.3.1. US
    • 3.3.2. 5EU
  • 3.4. Forecast Methodology
    • 3.4.1. Sources Used
    • 3.4.2. Sources Not Used
    • 3.4.3. Forecast Assumptions and Methods. Total Prevalent Cases of Celiac Disease
    • 3.4.4. Forecast Assumptions. Diagnosed Prevalent Cases of Celiac Disease
  • 3.5. Epidemiological Forecast for Celiac Disease (2013-2023)
    • 3.5.1. Total Prevalent Cases of Celiac Disease
    • 3.5.2. Age-Specific Total Prevalent Cases of Celiac Disease
    • 3.5.3. Sex-Specific Total Prevalent Cases of Celiac Disease
    • 3.5.4. Age-Standardized Total Prevalence of Celiac Disease
    • 3.5.5. Diagnosed Prevalent Cases of Celiac Disease
  • 3.6. Discussion
    • 3.6.1. Epidemiological Forecast Insight
    • 3.6.2. Limitations of the Analysis
    • 3.6.3. Strengths of the Analysis

4. Appendix

  • 4.1. Bibliography
  • 4.2. About the Authors
    • 4.2.1. Epidemiologists
    • 4.2.2. Reviewers
    • 4.2.3. Global Director of Therapy Analysis and Epidemiology
    • 4.2.4. Global Head of Healthcare
  • 4.3. About GlobalData
  • 4.4. About EpiCast
  • 4.5. Disclaimer

List of Tables

  • Table 1: Risk Factors for Celiac Disease
  • Table 2: Studies Reporting Temporal Trends for Celiac Disease and Calculated Rate of Change
  • Table 3: 6MM, Sources of Prevalence and Diagnosis Rates of Celiac Disease
  • Table 4: 6MM, Sources Not Used in Epidemiological Forecast for Celiac Disease
  • Table 5: 6MM, Total Prevalent Cases of Celiac Disease, Both Sexes, All Ages, N, Select Years 2013-2023
  • Table 6: 6MM, Age-Specific Total Prevalent Cases of Celiac Disease, Both Sexes, N (Row %), 2013
  • Table 7: 6MM, Sex-Specific Total Prevalent Cases of Celiac Disease, All Ages, N (Row %), 2013
  • Table 8: 6MM, Diagnosed Prevalent Cases of Celiac Disease, Both Sexes, All Ages, Select Years 2013-2023

List of Figures

  • Figure 1: 6MM, Total Prevalent Cases of Celiac Disease, Both Sexes, All Ages, N, 2013-2023
  • Figure 2: 6MM, Age-Specific Total Prevalent Cases of Celiac Disease, Both Sexes, N (Row %), 2013
  • Figure 3: 6MM, Sex-Specific Total Prevalent Cases of Celiac Disease, All Ages, 2013
  • Figure 4: 6MM, Age-Standardized Total Prevalence (%) of Celiac Disease, All Ages, by Sex, 2013
  • Figure 5: 6MM, Diagnosed Prevalent Cases of Celiac Disease, Both Sexes, All Ages, N, 2013-2023
Back to Top